The use of in silico analysis to engineer the best immunogenic epitope and produce the corresponding prophylactic antigen-based vaccines with C1 production platform in order to rapidly respond to viral pandemics

Conference Dates

October 1-6, 2023

Abstract

Please click Additional Files below to see the full abstract

31.pdf (72 kB)

This document is currently not available here.

Share

COinS